leisure time -WSS

leisure time

author：explore 2025-09-06 03:32:26 - browse：213

Adam's take main illustration — Molly Ferguson/STAT

For two days starting on Sunday, Moonlake Immunotherapeutics happily crunched numbers and shared results from a mid-stage clinical trial that depicted its experimental antibody in the most flattering terms possible.

The drug, called sonelokimab, was “changing the game” for the treatment of a debilitating skin condition called hidradenitis suppurativa, or HS, said Moonlake CEO Jorge Santos da Silva, on a call for investors and analysts. The drug’s benefit for patients placed it “at the top of the heap,” he added.

For other, equally important data from the same study that did not fit Moonlake’s home-run narrative, the company took a DIY approach. Curious about how sonelokimab performed against a treatment that’s already approved for HS? Pull out a calculator and do the math yourself. How badly did a higher dose of the drug underperform a lower dose? Take a guess.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： ChatGPT in medicine: STAT answers readers' burning questions
Next article： Departing Stanford president retracts two papers

WSS

Over 1,300 arrested in France in 4th night of protests over fatal police shooting of teen Nahel M.

Reanimated hearts work just as well for transplants, study finds

Xenotransplantation trials will require adjusting expectations, experts say

Apellis safety probe of eye disease drug centers on injection needle

Drug firms test therapies to halt Alzheimer’s before symptoms arise

Why more medical students aren't specializing in primary care

focus

leisure time

focus

As demand for Covid shots wanes, Moderna seeks its next success

2024 GOP presidential candidates spar over abortion in debate

At least 13 dead in Texas as scorching temps continue

FDA approves first new drug developed for postpartum depression

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Canadian wildfire dangers should prompt more proactive mitigation from government: Experts

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Xenotransplantation trials will require adjusting expectations, experts say

Hollywood unions extend contract negotiations for actors

Radiation, mainstay of cancer treatment, begins a fade

hotspot

A public health expert passes on football's full body collisions for youths

Canadian wildfire dangers should prompt more proactive mitigation from government: Experts

How Long Island became the ‘eugenics capital of the world’

U.K. agency declines to back Eli Lilly’s Mounjaro for type 2 diabetes

How to fix the rural physician shortage in the U.S.

Australia’s approach to dialysis celebrates life

entertainment

knowledge

leisure time

hotspot